Randomization 2 + Allo HSCT clinical trials

A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic Leukemia

This study looks at new treatments for adults with a type of blood cancer called acute lymphoblastic leukaemia (ALL). It aims to find better ways to use new targeted drugs and bone marrow transplants to improve recovery and long-term health for patients.